Natixis Twist Bioscience Corp Transaction History

Natixis

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$21.92 - $39.37 $1.28 Million - $2.3 Million	58,500 Added 71.29%	140,560 $3.35 Million
Q3 2022 Nov 14, 2022	BUY	$33.44 - $56.56 $2.74 Million - $4.64 Million	82,060 New	82,060 $2.89 Million
Q1 2022 May 13, 2022	SELL	$38.58 - $83.27 $341,973 - $738,105	-8,864 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$75.47 - $135.88 $2.74 Million - $4.94 Million	-36,362 Reduced 80.4%	8,864 $686,000
Q3 2021 Nov 12, 2021	BUY	$95.64 - $131.48 $4.33 Million - $5.95 Million	45,226 New	45,226 $4.84 Million
Q2 2021 Aug 13, 2021	SELL	$88.13 - $142.06 $1.83 Million - $2.95 Million	-20,766 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$105.48 - $207.97 $250,936 - $494,760	-2,379 Reduced 10.28%	20,766 $2.57 Million
Q4 2020 Feb 12, 2021	BUY	$76.64 - $167.89 $1.77 Million - $3.89 Million	23,145 New	23,145 $3.27 Million

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.55B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.